PDL acquires majority stake in Noden
PDL BioPharma Inc. is acquiring a majority stake in Noden Pharma DAC, a private specialty pharmaceutical company based in Ireland, which was formed in March 2016 to acquire established prescription medicines across various therapeutic areas from global pharma players.
- Specialty Pharmaceuticals
- Includes Earnout
- Partial Acquisition
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.